Antiparasitic Therapy
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 86 (6), 561-583
- https://doi.org/10.4065/mcp.2011.0203
Abstract
No abstract availableKeywords
Funding Information
- Agency for Healthcare Research and Quality
This publication has 123 references indexed in Scilit:
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infectionsMalaria Journal, 2010
- Evaluation of New Thiazolide/Thiadiazolide Derivatives Reveals Nitro Group-Independent Efficacy against In Vitro Development of Cryptosporidium parvumAntimicrobial Agents and Chemotherapy, 2010
- Drug Resistance in Visceral LeishmaniasisJournal of Biomedicine and Biotechnology, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaThe New England Journal of Medicine, 2009
- First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent AntimonyPLoS Neglected Tropical Diseases, 2009
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort studyBMJ, 2008
- Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in UgandaPLoS Clinical Trials, 2006
- Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and TinidazoleAntimicrobial Agents and Chemotherapy, 2006